The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
104 jobs Number of planned job losses
Announcement Date
27 November 2009
Employment effect (start)
Foreseen end date
Description
Belgian management of Wyeth, a company operating in the pharmaceutical industry, announced the cut of 120 jobs at its site in Louvain-la-Neuve. The announcement was made at an extraordinary works council meeting and concerns 69% of all employees mainly in administration, marketing and sales. Since October 2009, Wyeth is a subsidiary of Pfizer.
The number of job losses was reduced to 104 at the second official redundancy notification in March 2010.
Sources
28 November 2009: Vers L'Avenir
28 November 2009: L'Echo
Citation
Eurofound (2009), Wyeth Pharmaceuticals, Merger/Acquisition in Belgium, factsheet number 69970, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/69970.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
